Navigation Links
GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP
Date:12/6/2008

ASH (Abstract #401, Abstract #669)

A post hoc analysis of data from the ongoing EXTEND (Eltrombopag eXTENded Dosing study) trial of refractory and non-refractory ITP patients showed that PROMACTA induced long-lasting platelet count increases and reduced clinically significant bleeding symptoms. The analysis is being presented at ASH on Monday, December 8, 2008 at 12:00 noon, PST.

In addition, data from a survey of ITP patients showed that patients are willing to accept significant risks for treatment side effects in exchange for improved efficacy and convenient administration. The survey results are being presented at ASH on Monday, December 8, 2008 at 4:30 p.m., PST.

About PROMACTA

PROMACTA is an oral, non-peptide thrombopoietin receptor agonist that has been shown in pre-clinical research and clinical trials to stimulate the proliferation and differentiation of megakaryocytes, the bone marrow cells that give rise to blood platelets.

PROMACTA was discovered as a result of a research collaboration between GlaxoSmithKline and Ligand Pharmaceuticals (Nasdaq: LGND). It was developed by GlaxoSmithKline. GSK plans to submit a Marketing Authorization Application (MAA) for eltrombopag in Europe in 2008.

Important Safety Information

BOXED WARNING

PROMACTA may cause hepatotoxicity. Patients receiving therapy with PROMACTA must have regular monitoring of serum liver tests (see Laboratory Monitoring below). Discontinue PROMACTA if ALT levels increase to greater than or equal to 3X upper limit of normal (ULN) and are: progressive; or persistent for greater than or equal to 4 weeks, or; accompanied by increased direct bilirubin; or accompanied by clinical symptoms of liver injury or evidence for hepatic decompensation. Reinitiating treatment with PROMACTA
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinsons Disease
2. GEN Reports on the Trend Toward Predictive Toxicogenomics
3. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
4. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
5. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
6. Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
7. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
8. Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
9. Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia
10. Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio
11. Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014  Rigrodsky & Long, P.A.: , Do ... LCI )? , Did you purchase your shares ... 16, 2014, inclusive? , Did you lose money in ... want to discuss your rights? Rigrodsky ... Timothy J. MacFall , announces that a complaint has been ...
(Date:8/28/2014)... , Aug. 28, 2014 Reportlinker.com announces ... in its catalogue: Germany Aesthetic Lasers ... http://www.reportlinker.com/p02343442/Germany-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html Germany ... 2020 Summary GlobalData,s new report, "Germany ... 2020", provides key market data on the Germany ...
(Date:8/28/2014)... , Aug. 28, 2014 Pharmatech ... two-year investment into this game-changing method for matching ... Today, clinical trials target specific cancers, disease ... contributing factors for the cancer, in the first ... that this information may not be well known ...
Breaking Medicine Technology:Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 2Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 3Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 4Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 5Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 6Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 7Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 8Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 9Enrollment in Pharmatech's Revolutionary AccessPPM Program Launches 2
... 2011  At the Radiological Society of North America ... to enter the radiology display space.  The company ... to bring a comprehensive line of diagnostic-quality, medical-grade ... has set the standard for medical display technology," ...
... Ecology Coatings, Inc. (OTCQB:ECOC), a ... ultraviolet-curable advanced coatings, today announced it has developed ... of the healthcare industry.  The coating is applied ... is benzophenone free—a request that is becoming a ...
Cached Medicine Technology:Ecology Coatings Develops UV-Curable Coatings for Medical Wristbands 2Ecology Coatings Develops UV-Curable Coatings for Medical Wristbands 3
(Date:8/29/2014)... 29, 2014 Most dentists work during normal ... a break in their day to be able to go ... professionals to find a few hours during their increasingly busy ... Dental so important. It is now possible for people to ... , What is happening? , North York Dental has realized ...
(Date:8/29/2014)... Fort Washington MD (PRWEB) August 29, 2014 ... and Expo at the Hyatt Regency Orlando last week ... Jay Greenstein returned as a presenter. ... Healthcare Reform in the 21st Century was a standing ... Clinical Ah-hah Moments – Doctors of Chiropractic Leading the ...
(Date:8/29/2014)... City of Industry, CA (PRWEB) August 29, 2014 ... of Labor statistics, have suggested that Americans today are ... before, leaving workers overworked and overstressed. APEC Water believes ... they are offering a Labor Day Sale on their ... everyone well hydrated and healthy. From now until 9/2/2014, ...
(Date:8/29/2014)... 29, 2014 The Winscribe Board of ... Chief Executive Officer effective from 1st September 2014. Allen ... Winscribe. , “During this time of growth, there is ... said Matthew Weavers, Winscribe’s Founder and Chairman of the ... of commercial, IT and management experience gained in New ...
(Date:8/28/2014)... August 29, 2014 Fifty percent of ... all the time, twenty percent of Americans claim to ... their daily life. Adrenal Fatigue is the most common ... more of the classic symptoms. Tasks that were once ... things that previously didn’t cause irritation, experiencing weight gain ...
Breaking Medicine News(10 mins):Health News:North York Dental Provides Dental Services to Busy Professionals 2Health News:Sport and Spine Rehab’s CEO Presents at the Florida Chiropractic Association National Convention and Expo 2014 2Health News:Relax this Labor Day Weekend with Great Savings on Easy-Install, Do-It-Yourself Drinking and Whole House Water Filters 2Health News:Winscribe Names Greg Allen as CEO 2Health News:Peoria AlignLife Clinics Focus on Community Education 2
... Corp. Executives and Zambian Caregiver Speak with U.S. Leaders for ... ... Senate to pass Global AIDS, TB and Malaria Bill, WASHINGTON, ... healthcare company McKesson Corp. spoke with,lawmakers in Washington to emphasize the ...
... a biological distinction between breast cancers that depend ... to research published Friday, April 25th in the ... that hormone dependent breast cancers, which usually require ... the same biological pathway as hormone independent breast ...
... ligament injuries is key, experts say , , THURSDAY, April 24 ... tearing the knee ligament that connects the thighbone to the ... there,s now reason to suspect that this type of injury ... at the Mayo Clinic in Rochester, Minn., found that young ...
... WASHINGTON, April 24 The U.S. Senate voted,95 ... Act ("GINA," H.R.,493), which bars employers and health ... their own or their family members, genetic,information, on ... Policy and Communications at,the U.S. Conference of Catholic ...
... by USAID Administrator Henrietta H. Fore and PMI Coordinator,Admiral ... known as World Malaria Day, we,remember those taken or ... tragic because it is preventable. We must rededicate our,commitment ... Africa by focusing our,efforts on the most vulnerable, pregnant ...
... IM), As part of an ongoing commitment to ... Portland, Ore. today announced its,investment in the world,s most ... be the first medical center on the West,Coast - ... to house IMRISneuro; a fully,integrated operating room that combines ...
Cached Medicine News:Health News:Government and Corporate Support Together Help Africans Battling Malaria, AIDS 2Health News:Government and Corporate Support Together Help Africans Battling Malaria, AIDS 3Health News:Women Risk Bone Loss After Knee Surgery 2Health News:Women Risk Bone Loss After Knee Surgery 3Health News:From Henrietta H. Fore, USAID Administrator and Admiral Timothy Ziemer, PMI Coordinator on the Observance of World Malaria Day 2008 2Health News:Providence St. Vincent bringing IMRISneuro, the world's most advanced surgical MRI to Portland, Oregon 2Health News:Providence St. Vincent bringing IMRISneuro, the world's most advanced surgical MRI to Portland, Oregon 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: